BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7053701)

  • 1. Functional hyposplenia after splenic irradiation for Hodgkin's disease.
    Coleman CN; McDougall IR; Dailey MO; Ager P; Bush S; Kaplan HS
    Ann Intern Med; 1982 Jan; 96(1):44-7. PubMed ID: 7053701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced splenic atrophy in patients with Hodgkin's disease and non-Hodgkin's lymphomas.
    Dailey MO; Coleman CN; Kaplan HS
    N Engl J Med; 1980 Jan; 302(4):215-7. PubMed ID: 7350461
    [No Abstract]   [Full Text] [Related]  

  • 3. Vesiculated erythrocytes as a determination of splenic reticuloendothelial function in pediatric patients with Hodgkin's disease.
    Weiner MA; Landmann RG; DeParedes L; Leventhal BG
    J Pediatr Hematol Oncol; 1995 Nov; 17(4):338-41. PubMed ID: 7583390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment.
    Enrici RM; Anselmo AP; Iacari V; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
    Haematologica; 1998 Jul; 83(7):636-44. PubMed ID: 9718869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the risk of solid tumor following Hodgkin's disease.
    Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
    Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic injury caused by therapeutic irradiation.
    Dailey MO; Coleman CN; Fajardo LF
    Am J Surg Pathol; 1981 Jun; 5(4):325-31. PubMed ID: 7270781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the spleen structure during treatment of patients with generalized Hodgkin's disease].
    Gubareva AV; Markochev AB; Simbirtseva LP; Asaturian MA
    Eksp Onkol; 1988; 10(5):70-3. PubMed ID: 3208697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteraemia in adults after splenectomy or splenic irradiation.
    Selby C; Hart S; Ispahani P; Toghill PJ
    Q J Med; 1987 Jun; 63(242):523-30. PubMed ID: 3659267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spleen involvement in Hodgkin's lymphoma: assessment and risk profile.
    Rueffer U; Sieber M; Stemberg M; Gossmann A; Josting A; Koch T; Grotenhermen F; Diehl V;
    Ann Hematol; 2003 Jul; 82(7):390-6. PubMed ID: 12764547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver irradiation in stage IIIA Hodgkin's disease patients with splenic involvement.
    Lee CK; Bloomfield CD; Levitt SH
    Am J Clin Oncol; 1984 Apr; 7(2):149-57. PubMed ID: 6702719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma.
    Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Abe O; Saito T; Tanaka Y
    Hematology; 2015 May; 20(4):203-7. PubMed ID: 25131182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: An evaluation of the effects of splenectomy in Hodgkin's disease in patients undergoing extended field or total lymph node irradiation.
    Royster RL; Wassum JA; King ER
    Am J Roentgenol Radium Ther Nucl Med; 1974 Mar; 120(3):521-30. PubMed ID: 4816806
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined treatment strategy in over 200 children with Hodgkin's disease: graduated chemotherapy, involved field irradiation with low dosage and selective splenectomy. A report of the cooperative therapy study DAL-HD-82].
    Schellong G; Brämswig J; Ludwig R; Gerein V; Jobke A; Jürgens H; Kabisch H; Stollmann B; Weinel P; Gadner H
    Klin Padiatr; 1986; 198(3):137-46. PubMed ID: 3523020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection among 210 patients with surgically staged Hodgkin's disease.
    Coker DD; Morris DM; Coleman JJ; Schimpff SC; Wiernik PH; Elias EG
    Am J Med; 1983 Jul; 75(1):97-109. PubMed ID: 6859090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal consequences of irradiation of the spleen in lymphoma patients.
    Le Bourgeois JP; Meignan M; Parmentier C; Tubiana M
    Br J Radiol; 1979 Jan; 52(613):56-60. PubMed ID: 427353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of splenectomy on the haematological response to radiotherapy in Hodgkin's disease.
    Begent RH; Wiltshaw E
    Br J Haematol; 1974 Jun; 27(2):331-6. PubMed ID: 4843676
    [No Abstract]   [Full Text] [Related]  

  • 17. CT-pathologic correlations in Hodgkin's disease and non-Hodgkin's lymphoma.
    Breiman RS; Castellino RA; Harell GS; Marshall WH; Glatstein E; Kaplan HS
    Radiology; 1978 Jan; 126(1):159-66. PubMed ID: 619400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenic function: physiology and splenic hypofunction.
    Sills RH
    Crit Rev Oncol Hematol; 1987; 7(1):1-36. PubMed ID: 3304675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid diseases after treatment of Hodgkin's disease.
    Hancock SL; Cox RS; McDougall IR
    N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallium-67 scintiscan in the diagnosis of primary splenic non-Hodgkin's lymphoma after the treatment of Hodgkin's disease.
    Lee JD; Park CH; Griffith J; Vernick J
    J Nucl Med; 1992 Jun; 33(6):1183-5. PubMed ID: 1597736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.